Indonesia — Fishery/Seafood Products — Shrimp-Prawn

← back to leaderboard

Indonesia received 399 FDA import refusals in Shrimp-Prawn, part of Fishery/Seafood Products between 2023-Q3 and 2026-Q2. Volume peaked at 306 in 2025-Q3, with the trend rising sharply year-on-year. The most-cited issues are vetdrugres, nitrofuran, and mfr insan. No trade baseline is published for this commodity from Indonesia, so no per-$1B rate is shown here.

Of these, 369 were hazard refusals and 30 were paperwork refusals.

Exporting from Indonesia? Get an email when shipments from Indonesia are refused at the US border — before your buyers ask.

Quarterly rejections, last 12 quarters

0 2023-Q3 2023-Q3: 0 2 2023-Q4 2023-Q4: 2 0 2024-Q1 2024-Q1: 0 3 2024-Q2 2024-Q2: 3 11 2024-Q3 2024-Q3: 11 8 2024-Q4 2024-Q4: 8 24 2025-Q1 2025-Q1: 24 9 2025-Q2 2025-Q2: 9 306 2025-Q3 2025-Q3: 306 26 2025-Q4 2025-Q4: 26 8 2026-Q1 2026-Q1: 8 2 2026-Q2 2026-Q2: 2

Recent rejections